Amelioration of the Abnormalities Associated with Metabolic Syndrome by L-Norvaline in Hyperlipidemic Diabetic Rats Cover

.blurhash-client-img { display: none !important; }

Amelioration of the Abnormalities Associated with Metabolic Syndrome by L-Norvaline in Hyperlipidemic Diabetic Rats

European Pharmaceutical Journal

Volume 68 (2021): Issue 2 (December 2021)

By: S. Dobhal, S. Baliyan, MF. Singh, S. Bisht and S. Setya

Open Access

|Feb 2022

Authors

S. Dobhal

School of Pharmaceutical Sciences, Sardar Bhagwan Singh University, Dehradun, India

S. Baliyan

School of Pharmaceutical Sciences, Sardar Bhagwan Singh University, Dehradun, India

MF. Singh

mamta_fr2002@yahoo.co.in

School of Pharmaceutical Sciences, Sardar Bhagwan Singh University, Dehradun, India

S. Bisht

Babu Banarasi Das University, Lucknow, India

S. Setya

SGT College of Pharmacy, SGT University, Gurugram, India

DOI: https://doi.org/10.2478/afpuc-2021-0015 | Journal eISSN: 2453-6725

Journal RSS Feed

Language: English

Page range: 16 - 26

Submitted on: Apr 3, 2021

Accepted on: Oct 1, 2021

Published on: Feb 9, 2022

Published by: Comenius University in Bratislava, Faculty of Pharmacy

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Insulin resistance,

Metabolic syndrome,

Related subjects:

Pharmacy, other

© 2022 S. Dobhal, S. Baliyan, MF. Singh, S. Bisht, S. Setya, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 68 (2021): Issue 2 (December 2021)Next article